Group items tagged

A groundbreaking study analysing data from nearly 600,000 cancer patients in England has shed light on the increased risk of second cancers among breast cancer survivors. The research conducted by University of Cambridge in association with the Lancet Regional Health-Europe studied data from over 580,000 female and over 3,500 male breast cancer survivors diagnosed between 1995 and 2019 using the National Cancer Registration Dataset. The findings suggest that survivors of breast cancer, the most prevalent cancer in the UK, face a substantially higher risk of developing second primary cancers. According to the research, female survivors exhibited a twofold increase in the risk of contralateral breast cancer compared to the general population. The data highlighted an 87 per cent greater risk of endometrial cancer, a 58 per cent greater risk of myeloid leukemia, and a 25 per cent greater risk of ovarian cancer in female survivors.

PRODUCT DESCRIPTION INSTYLER IN PAKISTAN It's not a brush. It's not a flat iron. It's not a curling iron. It's the InStyler® rotating hot iron! The InStyler® rotating hot iron is a totally new styling and straightening tool unlike any hair styling product ever invented!The secret to the InStyler® iron lies in its rotating heated polishing cylinder, along with four rows of precision-aligned bristles. HOW IT WORKS:OPENTELESHOP when you run the InStyler® rotating hot iron through your hair, the first set of bristles gently sort and separate your hair strands. Then the rotating heated polishing cylinder gently glides over your hair, smoothly polishing, straightening, and styling each strand. Finally, the second set of bristles puts the finishing touch on your hair, leaving you with shiny, silky, hair! It's truly amazing!And the best part is, because of the InStyler® rotating hot iron's patented design, your hair won't get smashed and baked by the super-intense heat of a flat iron or other "hot" tools. In fact, the InStyler® rotating hot iron uses less heat than traditional hot tools, and delivers better results. How? Because the InStyler® rotating hot iron's gentle heat in conjunction with the rotating motion of the polishing cylinder literally polishes your hair strands individually so it doesn't need extreme heat to get amazing results. YOUR HAIR WILL BE SHINIER, BOUNCIER AND FULL OF LIFT AND LIFE! Plus, the InStyler® rotating hot iron does so much more than any styling tool out there. Get lift and fullness - right from the root! Get a sexy flip in seconds. Straighten even the toughest, most coarse hair - and still get fullness and style without the stick-straight "flatness" of a flat iron. Do a full style in 8 minutes - and change it again in two minutes! Wrap your hair around the rotating polishing cylinder - and get an amazing curl that lasts all day! If you can hold it, you can do it with the InStyler® rotating hot

PRODUCT DESCRIPTION ROTI MAKER IN PAKISTAN Enjoy the easiest way of making Chapati with electric Roti Maker, now available just for you. Make thin and perfect circular chapatis in least efforts with this amazing product. The product is easy to use and can be carried anywhere along with you. Making food is no more a tension now; just get simpler with electric roti maker. This product is provided with a handle that makes it easy to press the plates together and knobs that help you to lift up the top plate. Constantly rolling the dough and standing in front of the hot stove can be very tiring experience. Enjoy the easy way of making perfect roti with electric roti maker. It will help you in making soft chapatis without putting in much effort. The greatest advantage of roti maker is that it saves you a great deal of time which can be utilized in other important things. With this convenient way of making roti you can now make number of chapattis while you guests at home without any trouble. HOW TO USE? 1- Place dough at the upper edge of the lower base of the roti maker 2-Now close the lid and press the dough for one. The idea is two bring roti exactly in the middle. 3-Allows that to cook for 20 seconds and turn it to the other side. 4-Now close the roti with the lid for 20 seconds and reopen it. 5-You will see fluffy roti ready to eat now. ROTI MAKER BENEFITS ➤ Rolls And Cooks Chapattis In Few Seconds ➤ Save Efforts, Time And Cooking Oil ➤ Non-Stick Plates Cooking Reduces Calories ➤ Temperature Can Be Controlled By Thermostat ➤ Works On 230/240 V Ac, 50 Hz ➤ Consumes The Power 900 Watts ➤ Got Stainless Steel Body ➤ Roti Maker Is An Excellent Gift Item ➤ Great Utility In Types Of Households Tags & Keywords Roti Maker Roti Maker In Pakistan,gas Roti Maker price In Pakistan,philips Roti Maker Price In Pakistan,roti Maker Online,anex Roti Maker In Pakistan,roti Maker In Pakistan Video,roti Maker In Karachi,westpoint Roti Maker In Pakistan,naaptolpk,

Covid-19 booster jab can now be administered sooner than six months after the second dose to certain vulnerable people as guideline in the UK Health Security Agency (UKHSA) Green Book has been updated. With the change in the guidance, care home residents who have been given their second vaccine dose at different times will be able to be jabbed in the same session, as long as it has been at least five months since their last dose. It may also help with other vulnerable groups, such as housebound patients to have their flu and Covid-19 vaccines at the same time. The move will also benefit those who are about to receive immunosuppressive treatment as they can get the booster from a minimum of four months after their second dose. Health secretary Sajid Javid said: "This updated guidance will ensure healthcare professionals have the necessary flexibility in the booster programme, allowing more vulnerable people to be vaccinated where it makes operational sense to do so." Vaccines minister Maggie Throup also encouraged eligible people to book their booster jab and secure protection.

The University of Lincoln has clinched the top spot on The Guardian's 2024 list for pharmacy and pharmacology studies. This marks a significant advancement from its second-place position in the 2023 rankings, where Ulster University had secured the leading position. Interestingly, Ulster has moved down to claim the second spot this year. Forty universities were assessed using eight criteria, which encompass student satisfaction with teaching, the effectiveness of feedback from instructors, student-to-staff ratio, expenditure per student (excluding academic staff costs), and the average UCAS scores of entrants under 21. Also included were the effectiveness of teaching methods, the proportion of students securing graduate-level employment or pursuing further studies within 15 months of graduation, and the percentage of first-year students progressing into their second year. Among the 40 universities in the ranking list, the University of Lincoln achieved a perfect score of 100 out of 100, followed by Ulster (96.2), Portsmouth (87.9), Leeds (86.3), Glasgow (85.7), Sunderland (84.3), St George's (84.3), Aberdeen (81.3), UCL (81), and Queen's, Belfast (80.1).

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a second "bivalent" vaccine as a Covid-19 booster. The updated booster vaccine made by Pfizer/BioNTech, targeting two coronavirus variants, has been approved for use in individuals aged 12 years and above. In each dose of the booster vaccine, 'Comirnaty bivalent Original/Omicron', half of the vaccine (15 micrograms) targets the original virus strain and the other half (15 micrograms) targets Omicron (BA.1). Dr June Raine, MHRA chief executive said: "I am pleased to announce that we now have a second approved vaccine for the UK Autumn booster programme. The clinical trial of the Pfizer/BioNTech bivalent vaccine showed a strong immune response against the Omicron BA.1 variant as well as the original strain. Bivalent vaccines are helping us to meet the challenge of an ever-evolving virus, to help protect people against Covid-19 variants. We have in place a comprehensive safety surveillance strategy for all UK-approved Covid-19 vaccines, and this will include the updated booster we approved today."

Going through a risky medical treatment? Clear all your doubts through medical second opinion online from best doctors on Medical Opinion.

The Department of Health and Social Care's (DHSC) response to the 2019 consultation on community pharmacy drug reimbursement reform has paved the way for the second phase of consultation with the pharmacy negotiator. The second round of the consultation will focus on eight proposals: Changes to the way Category A prices are set Changes to how medicine margin is distributed in Category M drugs Changes to how Category C prices are set for drugs with multiple suppliers Inclusion of non-medicinal products in the Drug Tariff Changes to the way prices of drugs in non-Part VIIIA are set Changes to arrangements for reimbursement and procurement of 'specials' Changes to reimbursement of generically prescribed drugs and appliances dispensed as 'specials' Changes to the discount deduction scale The Pharmaceutical Services Negotiating Committee has been discussing these proposals with the DHSC and the outcome was featured in the final package of the 'Community pharmacy in 2016/17 and beyond' document.

Persons who want to relocate to Spain have very good news in this sense, as Spain is the second country in the world offering the highest level of quality of life.

Get medical second opinion from the best doctors and top medical centres. We are here to help you get the right diagnosis and treatment.

Ne ratez pas une seconde de tous les Conseils pour Brûler la Graisse que nous avons pour vous - Assurez-vous que votre son n'est pas muet et veuillez patienter quelques secondes que la vidéo démarre.  

Wheelchair Recliner reclining wheelchair is a type of mobility device similar to a standard wheelchair except that its back can be reclined. It is designed for people with limited mobility as a result of illness, injury, or disability who find sitting in an upright position to be uncomfortable or impossible. A reclining wheelchair allows several key parts of the device, including the foot rests and backrest, to be adjusted to accommodate various needs and positions. Wheelchair Recliner are available in both folding and rigid models. Folding recliner wheelchairsare convenient if you will be transporting the wheelchair in the trunk of a car or need to store it flat. However, folding wheelchairs are often heavy and require adjusting and locking prior to each use, which impacts their safety and comfort. Rigid models are lightweight - many are made with ultralight materials such as titanium and aircraft aluminum - and usually offer more customization options and comfort than folding wheelchairs. Reclining Wheelchair With Commode For Sale Reclining wheelchair With Commode multi function can be used to lie down, also manual wheelchair with an adjustable treadle up and down or leg rest and can also be used for the toilet with a plastic bucket under the seat and easy to clean it.Reclining wheelchair is very efficient and multi function because people could use it to get 4 functions in 1 Wheelchair.Reclining Wheelchair with adjustable footrest and commode. Reclining Wheelchair With Commode Features The wheelchair can be folded within very easily within seconds, making it easier during travels and outings. The backrest of the chair can be easily reclined, giving the user the freedom to relax by not moving up from the chair. The footrest can be inclined and adjusted so as to make the user comfortable during reclining or otherwise. A well paded thigh support is an add-on to the footrest. The front and rear wheels of the chair are designed and placed i

As the government today (November 15) announced plans to expand Britain's booster programme for Covid-19 vaccinations to cover all adults aged over 40, NHS Confederation welcomed the move. The announcement follows the Joint Committee on Vaccination and Immunisation (JCVI) statement that all healthy adults aged 40-49 should be offered a booster, six months after their second dose, and that 16 and 17 year olds should be invited to have a second dose. Accepting the JCVI's advice, health and social care secretary Sajid Javid said: "All 4 parts of the UK intend to follow the JCVI's advice. "We know immunity to Covid-19 begins to wane after 6 months and new data published today shows a third dose boosts protection against symptomatic infection to more than 90% - this highlights just how important it is that everyone eligible gets their top-up jabs as soon as possible."

Data crunched by an online pharmacy delivery company paints a concerning picture for the pharmacy sector in England. Gophr's 'Prescription For Pressure' initiative reveals a challenging time for the sector and is supported by separate analysis by the BBC showing that the number of pharmacies in England is at its lowest since 2010. In addition, new powers being introduced for pharmacists to prescribe common prescription drugs and perform routine tests create an even greater workload for already overstretched pharmacists. Gophr's data reveals that: * Each pharmacy in England serves an average of 6,078 people. * In 2022, pharmacists dispensed 1.043 billion prescriptions, 26.3 million more than 2021. * A single pharmacy in England dispensed 248 prescriptions a day on average in 2022. Based on the most up-to-date statistics from the Office for National Statistics, NHS England and Statista, Gophr's calculations show that pharmacists have around 116 seconds to dispense a prescription, which is less time than the 180 seconds it takes to make a Quarter Pounder at McDonald's.

A total of 525 candidates have passed the common registration assessment for pharmacists held in November, the regulators GPhC and PSNI have announced on Tuesday. With 937 candidates sitting for the registration assessment, held jointly by the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI) on 3 November, the pass rate was 56 per cent, down from the 61 per cent for the Autumn 2021. Among the GPhC candidates, 59 per cent were sitting for the first time, 30 per cent for the second time and 8 per cent for the third time. (The break-up was not available for the 3 per cent PSNI candidates.) In comparison, for the June sitting 89 per cent of candidates were sitting for the first time, 7 per cent were sitting for the second time and 4 per cent were sitting for the third time. "We would like to congratulate the successful candidates and we look forward to them joining our register and continuing to the next stage of their career," Duncan Rudkin, GPhC chief executive said.

New GSK raised its 2022 forecast for the second time this year, after third-quarter earnings and sales topped estimates, continuing its strong start as a standalone prescription medicine and vaccine business since carving out its consumer health division Haleon. After years of underperformance relative to its peers and missing out on the lucrative market for the first set of COVID-19 vaccines, GSK has delivered a string of strong results. The latest is led by a record quarter for its blockbuster shingles vaccine Shingrix and higher-than-expected revenue from its COVID therapy, Xevudy. Having survived a revolt by activist investors Elliott and Bluebell last year, GSK's prospects have been boosted by clinical trial success, though concerns remain around U.S. litigation over heartburn drug Zantac. Thousands of lawsuits have been filed in the United States against a raft of drugmakers over allegations the heartburn drug contains a probable carcinogen.

The Department of Health and Social Care (DHSC) is encouraging people to come forward for their first and/ or second dose of the Covid vaccine before the free offer ends on Friday (30 June). The NHS's world-leading vaccination programme has so far delivered over 146 million Covid jabs. Building on the success of autumn and spring booster programmes, a seasonal, targeted vaccination offer will remain open for those most at risk, in line with advice from the Joint Committee on Vaccination and Immunisation (JCVI). Health Minister Maria Caulfield said: "As we live with Covid without restrictions on our freedoms, it is right that we move towards a more targeted vaccination offer that prioritises those most at risk, so we can focus our efforts on cutting waiting lists for NHS treatment - one of the Prime Minister's top five priorities. As the offer for any adult to get a Covid vaccine comes to an end on 30 June, I would urge those who have not yet come forward to choose to have the first and second Covid vaccine. It takes minutes to get your jab and thousands of sites are open across England." This year's spring booster programme continues to gather pace, with over two million eligible people receiving their vital top-up dose.

The European Union's population shrank for a second year running last year, the bloc's statistics office said on Monday, as the region reels from over two million deaths from the coronavirus. According to Eurostat, the population of the 27 countries that make up the bloc fell by close to 172,000 from the previous year and over 656,000 from January 2020. "In 2020 and 2021 the positive net migration no longer compensated for the negative natural change in the EU and, as a consequence, the EU total population has been decreasing," it said, pointing to impacts from the pandemic. The number of deaths began outstripping births in the EU a decade ago, but immigration from outside the bloc helped offset the gap until the first year of the pandemic. The previous time the EU had registered a fall in population was in 2011 - the only other time since 1960 - but this rapidly picked up due to net migration.

Labour Party leader Keir Starmer leader has tested positive for Covid-19 for a second time, a spokesperson confirmed on Wednesday (January 5). Starmer had been due to face prime minister Boris Johnson at a question and answer session in parliament later today. His deputy, Angela Rayner, will take his place, the spokesperson added. Starmer had tested positive for Covid-19 last October and self-isolated four times after coming into contact with other positive cases on several occasions.

UK regulator has approved a second oral antiviral for early treatment of Covid-19 in high-risk adults, after molnupiravir. The Medicines and Healthcare products Regulatory Agency (MHRA) gave its nod for a new treatment called Paxlovid (PF-07321332 and ritonavir), after finding it safe and effective at reducing the risk of hospitalisation and death in people diagnosed with mild Covid-19 infection. Developed by Pfizer, Paxlovid prevents the multiplying of virus, helping the body to overcome the infection. A clinical trial for the treatment in high risk individuals revealed that a five-days course of Paxlovid reduces the risk of hospitalisation and death by 89 per cent. It further revealed that Paxlovid is most effective when taken in the early stage of infection. Dr June Raine, MHRA chief executive, said: "We now have a further antiviral medicine for the treatment of Covid-19 that can be taken by mouth rather than administered intravenously. This means it can be administered outside a hospital setting, before Covid-19 has progressed to a severe stage."